RT

RTW Biotech Opportunities Ltd

Overview

Corporate Details

ISIN(s):
GG00BKTRRM22
LEI:
549300Q7EXQQH6KF7Z84
Country:
United States of America
Address:
40 10TH AVE, 10014 NEW YORK
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

No description available.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for RTW Biotech Opportunities Ltd. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-22 08:00
Transaction in Own Shares
Transaction in Own Shares
English 10.6 KB
2025-08-19 08:01
Report Publication Announcement
Notice of Interim Results
English 13.6 KB
2025-08-19 08:00
Capital/Financing Update
Strategic Funding Agreement with Aquestive
English 15.0 KB
2025-08-15 08:00
Transaction in Own Shares
Transaction in Own Shares
English 10.6 KB
2025-08-14 08:00
Fund Information / Factsheet
Monthly Valuation Update and Factsheet
English 29.3 KB
2025-07-17 08:00
Regulatory News Service
Update on Kailera Therapeutics
English 15.4 KB
2025-07-15 08:00
Fund Information / Factsheet
Monthly Valuation Update and Factsheet
English 32.5 KB
2025-07-10 08:00
M&A Activity
Merck to acquire Verona Pharma
English 15.7 KB
2025-07-03 18:34
Major Shareholding Notification
Holding(s) in Company
English 51.0 KB
2025-03-31 08:00
Annual Report
Annual Financial Report
English 1.6 MB
2025-03-28 08:00
Transaction in Own Shares
Transaction in Own Shares
English 10.6 KB
2025-03-26 08:00
Transaction in Own Shares
Transaction in Own Shares
English 10.6 KB

Automate Your Workflow. Get a real-time feed of all RTW Biotech Opportunities Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for RTW Biotech Opportunities Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Medesis Pharma S.A. Logo
Biotech creating CNS and oncology therapies using a proprietary drug delivery platform.
France ALMDP
Medicofarma Biotech Spolka Akcyjna Logo
Biotech R&D firm developing novel drugs, devices, and therapies with a focus on oncology.
Poland MDB
Medigene AG Logo
An immuno-oncology platform creating T cell receptor (TCR)-guided therapies to treat cancer.
Germany MDG1
MedinCell S.A. Logo
Develops and licenses long-acting injectable therapies using proprietary technology.
France MEDCL
Medivir Logo
Clinical-stage pharma firm developing tumor-directed therapies for high-need cancer patients.
Sweden MVIR
Mendus Logo
Developing immunotherapies using dendritic cells to prevent recurrence of AML & ovarian cancer.
Sweden IMMU
Merck KGaA Logo United States of America 6MK
Sweden MBOLIC
Milton Essex Spolka Akcyjna Logo
Develops AI-powered, non-invasive systems for allergy diagnostics & personalized medicine.
Poland MTN
Modus Therapeutics Holding AB Logo
Clinical-stage biotech developing sevuparin for sepsis, septic shock, and inflammation.
Sweden MODTX